United StatesBreaking News

President Donald Trump again pushed back his deadline for Iran to strike a deal with the US or face more attacks, saying talks with the country were going "very well." Bloomberg's Laura Davison reports.

Nicolás Maduro appeared in a Manhattan federal court Thursday as the US pushes forward with a broad drug-trafficking and narco-terrorism conspiracy case against the ousted Venezuelan leader. Bloomberg's Christina Ruffini reports from New York.

RoboSense CEO Mark Qiu talks about the key takeaways of their first-ever profitable quarter since 2014. He explains how the shift from analog to digital LiDAR will lift the company's performance and is a great cost advantage

enVVeno Medical (NASDAQ:NVNO), a clinical-stage medical device company developing innovative solutions for the treatment of chronic venous insufficiency (CVI), today reported its financial results for the full year ended December 31, 2025.

United-Guardian (NASDAQ:UG), a diversified manufacturer of pharmaceutical, cosmetic, and healthcare products, today reported its financial results for the full year ended December 31, 2025.

Carnival (NYSE:CCL), the world’s largest leisure travel company, today reported record-breaking financial results for the first quarter of 2026, signaling a robust start to the fiscal year.

Adagio Medical Holdings (NASDAQ:ADGM), a specialist in catheter ablation technologies for cardiac arrhythmias, reported a substantial narrowing of its net loss for the fiscal year ended Dec. 31, 2025, as the company realized the benefits of an aggressive cost-reduction strategy and a streamlined corporate profile.

Hydrofarm Holdings Group (NASDAQ:HYFM), a leading independent distributor and manufacturer of controlled environment agriculture (CEA) equipment and supplies, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

TMC the metals company (NASDAQ:TMC), a company focused on collecting polymetallic nodules from the deep seabed to supply critical battery metals, reported its fourth-quarter and full-year 2025 financial results along with a corporate update on March 27, 2026.

Werewolf Therapeutics (NASDAQ:HOWL), an innovative biopharmaceutical company developing "inducible" cytokines to treat cancer, today announced it has initiated a formal process to explore strategic alternatives.

Satellos Bioscience (NASDAQ:MSLE), a biotechnology company focused on developing small-molecule therapies that modulate muscle stem cell regeneration, reported its full-year 2025 financial results and provided updates on recent corporate and clinical milestones.

Humacyte (NASDAQ:HUMA), a pioneer in universally implantable, bioengineered human tissues, today announced its financial results for the fourth quarter and full year ended December 31, 2025.